Astronics Competitors

Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Astronics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Astronics in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
7.2210.3913.56
Details
Intrinsic
Valuation
LowReal ValueHigh
8.8011.9715.14
Details
Naive
Forecast
LowNext ValueHigh
6.9510.1213.29
Details
2 Analysts
Consensus
LowTarget PriceHigh
14.0016.5019.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Astronics. Your research has to be compared to or analyzed against Astronics' peers to derive any actionable benefits. When done correctly, Astronics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Astronics Cp.

Astronics Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Astronics and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Astronics and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Astronics Cp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Astronics Competition Risk-Adjusted Indicators

Nowadays, there is a big difference between Astronics stock performing well and Astronics company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Astronics' multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean
Deviation
Jensen
Alpha
Sortino
Ratio
Treynor
Ratio
Semi
Deviation
Information
Ratio
Expected
Shortfall
Potential
Upside
Value
At Risk
Maximum
Drawdown
LMT 1.17 (0.01)  0.00 (0.21)  0.00  0.06  0.00  2.52 (2.41)  5.73 
OMWS 14.58  3.44  0.16 (2.45)  11.68  0.14 (43.65)  53.85 (33.33)  143.71 
INTC 1.84 (0.23)  0.00 (0.38)  0.00 (0.12)  0.00  3.14 (3.64)  10.50 
XOM 2.00  0.24  0.08  0.06  2.97  0.1 (1.71)  3.03 (3.96)  11.86 
JPM 1.47 (0.11)  0.00 (0.30)  0.00 (0.06)  0.00  2.98 (3.00)  10.78 
PG 1.24  0.06  0.00 (0.12)  0.00  0.07  0.00  2.54 (2.30)  8.89 
CAT 1.76 (0.15)  0.00 (0.34)  0.00 (0.07)  0.00  3.20 (4.35)  10.92 
CSCO 1.56 (0.21)  0.00 (0.40)  0.00 (0.09)  0.00  2.73 (3.26)  17.06 
MRK 1.07  0.29  0.33  0.38  0.99  0.27 (1.23)  2.16 (1.65)  7.61 

Cross Equities Net Income Analysis

Compare Astronics Cp and related stocks such as Lockheed Martin Corp, Omnia Wellness, Intel Corp, Exxon Mobil Corp, JP Morgan Chase, Procter Gamble, Caterpillar, Cisco Systems, and Merck Company Net Income Over Time
Select Fundamental

2010201120122013201420152016201720182019202020212022
LMT2.7 B2.7 B2.7 BB3.6 B3.6 B5.2 BBB6.2 B6.8 B6.3 B5.8 B
INTC19.9 B12.9 B19.9 B19.9 B19.9 B19.9 B10.3 B19.9 B19.9 B19.9 B19.9 B10.3 B13.8 B
XOM30.5 B41.1 B44.9 B32.6 B32.5 B16.1 B7.8 B19.7 B20.8 B14.3 B(22.4 B)23 B24.7 B
JPM17.6 B17.6 B19.9 B16.6 B20.1 B22.7 B22.8 B22.6 B30.7 B34.6 B27.4 B46.5 B39.3 B
PG12.7 B10.8 B11.3 B11.6 BB10.5 B15.3 B9.8 B3.9 B13 B14.3 B16.5 B15 B
CAT4.9 B4.9 B5.7 B3.8 B2.5 B2.5 B(67 M)754 M6.1 B6.1 BB6.5 B5.6 B
CSCOBBBBB11.2 B11.2 B11.2 B11.2 B11.2 B10.6 B12.2 B11.4 B
MRK6.3 B6.3 B6.2 B4.4 B11.9 B4.4 B3.9 B2.4 B6.2 B9.8 B7.1 B13 B10.9 B

Astronics Cp and related stocks such as Lockheed Martin Corp, Omnia Wellness, Intel Corp, Exxon Mobil Corp, JP Morgan Chase, Procter Gamble, Caterpillar, Cisco Systems, and Merck Company Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Astronics Cp financial statement analysis. It represents the amount of money remaining after all of Astronics Cp operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income Available to Non-controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Astronics Competitive Analysis

The better you understand Astronics competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Astronics' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Astronics' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ATROLMTOMWSINTCXOMJPMPGCATCSCOMRK
 0.60 
 10.00 
Astronics
 0.27 
 416.38 
Lockheed
 2.70 
 0.38 
Omnia
 0.0273 
 36.68 
Intel
 1.51 
 83.53 
Exxon
 0.57 
 111.98 
JP Morgan
 1.34 
 146.64 
Procter
 0.41 
 173.05 
Caterpillar
 1.10 
 42.42 
Cisco
 1.58 
 94.10 
Merck
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Stock Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Number of Shares Shorted
Shares Owned by Insiders
Current Ratio
Profit Margin
EBITDA
Operating Margin
Current Valuation
Cash Flow from Operations
Retained Earnings
Current Asset
Five Year Return
Beta
Price to Book
Shares Outstanding
Total Debt
Return On Equity
Price to Earning
Z Score
Shares Owned by Institutions
Return On Asset
Book Value Per Share
Cash and Equivalents
Price to Earnings To Growth
Current Liabilities
Total Asset
Short Ratio
Last Dividend Paid
Price to Sales
Market Capitalization
Cash per Share
Net Income
Earnings Per Share
Debt to Equity
Revenue
Working Capital
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Astronics Competition Performance Charts

Complement your Astronics position

In addition to having Astronics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cancer Fighters Thematic Idea Now

Cancer Fighters
Cancer Fighters Theme
Biotech and medical diagnostic companies that work on researching drugs or manufacturing of medical and therapeutics equipment that is directly related to the research, treatment, and detection of cancer or cancer related diseases. The Cancer Fighters theme has 60 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cancer Fighters Theme or any other thematic opportunities.
View All  Next Launch Cancer Fighters
Please continue to Astronics Correlation with its peers. Note that the Astronics Cp information on this page should be used as a complementary analysis to other Astronics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Astronics Stock analysis

When running Astronics Cp price analysis, check to measure Astronics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astronics is operating at the current time. Most of Astronics' value examination focuses on studying past and present price action to predict the probability of Astronics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Astronics' price. Additionally, you may evaluate how the addition of Astronics to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Is Astronics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Astronics. If investors know Astronics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Astronics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
-0.93
Market Capitalization
326.6 M
Quarterly Revenue Growth YOY
0.097
Return On Assets
-0.0305
Return On Equity
-0.0645
The market value of Astronics Cp is measured differently than its book value, which is the value of Astronics that is recorded on the company's balance sheet. Investors also form their own opinion of Astronics' value that differs from its market value or its book value, called intrinsic value, which is Astronics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Astronics' market value can be influenced by many factors that don't directly affect Astronics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Astronics' value and its price as these two are different measures arrived at by different means. Investors typically determine Astronics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Astronics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ATRO
 Stock
  

USD 10.00  0.06  0.60%   

Astronics Cp competes with Lockheed Martin, Omnia Wellness, Intel Corp, Exxon, and JP Morgan; as well as few others. The company conducts business under Industrials sector and is part of Aerospace & Defense industry. Analyzing Astronics competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Astronics to its intrinsic valuation because they are able to contrast its competitors on a relative basis.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Astronics competition on your existing holdings. Please continue to Astronics Correlation with its peers.
  
Refresh
The value of Return on Investment is estimated to slide to -8.01. The value of Return on Average Assets is estimated to slide to -0.04. Astronics Net Current Assets as percentage of Total Assets are quite stable at the moment as compared to the past year. The company's current value of Net Current Assets as percentage of Total Assets is estimated at 36.91. Asset Turnover is expected to rise to 0.82 this year, although the value of Current Assets will most likely fall to about 329 M.